Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Vaccines made from a patient's white blood cells and tumor cells may make the body
build an immune response to kill tumor cells. Drugs used in chemotherapy use different ways
to stop tumor cells from dividing so they stop growing or die. Combining vaccine therapy with
chemotherapy may kill more tumor cells.
PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy combined with
leucovorin and fluorouracil in treating patients who have undergone surgery to completely
remove stage II or stage III colon cancer.